Jiangsu Jibeier Pharmaceutical Co. Ltd. (688566.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 25.92

From 52W high−6.58%

Volume1.37M

Market capCNY 5.11B

P/E (TTM)19.5x

P/S (TTM)5.3x

Div yield0.99%

Key dataSep 18, 2026

Open

CNY 25.92

From 52W high

−6.58%

Volume

1.37M

Market cap

CNY 5.11B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

16.9x

P/E (TTM)

19.5x

RSI (14)

58.8

MomentumView details →

1D Return

−3.31%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

19.5x

EV/EBITDA

16.9x

EV/Sales

4.6x

P/S (TTM)

5.3x

P/B (TTM)

2.1x

ProfitabilityView details →

Gross Margin

89.59%

Net Margin

25.65%

EBITDA Margin

27.51%

ROE (TTM)

10.24%

ROA (TTM)

9.33%

Asset Turnover

0.36x

GrowthView details →

Revenue YoY

+9.58%

EPS YoY

+13.30%

FCF YoY

+306.03%

Revenue CAGR 3Y

+13.85%

EPS CAGR 3Y

+16.43%

EBITDA YoY

—

MomentumView details →

1D Return

−3.31%

YTD Return

—

1Y Return

—

RSI (14)

58.8

vs 50D SMA

+2.80%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

9.35x

Quick Ratio

9.08x

Div Yield

0.99%

Div Rate

CNY 0.26

Div Growth 1Y

+0.00%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

990.68M

Net Income (TTM)

254.07M

Op. CF (TTM)

182.34M

Latest newsMore news →

Jibeier Pharmaceutical held an online investor briefing for its 2026 half-year results on September 17, 2026, attended by its chairman, CFO, board secretary and an independent director.3d ago

Jibeier announced a cash dividend of 2.6 yuan per 10 shares (tax inclusive), totaling 52.2864 million yuan (tax inclusive).24d ago

Similar companies

珍宝岛603567.SH 圣诺生物688117.SH 人民同泰600829.SH 千金药业600479.SH Shenzhen Hepalink Pharmaceutical Group Co., Ltd.09989.HK 津药药业600488.SH Find similar companies →

Latest newsMore news →

Jibeier Pharmaceutical held an online investor briefing for its 2026 half-year results on September 17, 2026, attended by its chairman, CFO, board secretary and an independent director.3d ago Jibeier announced a cash dividend of 2.6 yuan per 10 shares (tax inclusive), totaling 52.2864 million yuan (tax inclusive).24d ago